Anzeige
Mehr »
Login
Sonntag, 17.01.2021 Börsentäglich über 12.000 News von 656 internationalen Medien
Ganz selten: Bewegende Meldung! Wird mit dieser News am Montag ein Super-Hype ausgelöst?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrBoehringer Ingelheim and Enara Bio join forces to discover cancer immunotherapies
FrVerona completes enrolment in pilot study of potential COVID-19 inhaler
FrUS breakthrough designation for ligelizumab in chronic spontaneous urticaria
FrNICE backs GSK's Zejlua in advanced ovarian cancer
DoNHS England selects supermarket Asda to operate COVID-19 vaccination centre
DoEU approval for ViiV's Tivicay for children living with HIV
DoValneva partners with Oxford Immunotec on T cell analysis for COVID-19 vaccine
DoGilead and Vir unite to find a 'functional cure' for hepatitis B
MiRoche's Tecentriq/Avastin combo improves survival in liver cancer
MiDiurnal seeks marketing authorisation for Chronocort in the UK
MiEli Lilly announces mid-stage trial success for donanemab in Alzheimer's
MiSynairgen begins large-scale trial of inhaled COVID-19 treatment
DiBiogen and Apple partner on cognitive health study
DiICR researchers identify potential new treatment for drug-resistant prostate cancer
DiDHSC publishes 'UK Rare Disease Framework'
DiUK government unveils 'largest vaccination programme in British history'
MoBoehringer Ingelheim announces partnership with Google
MoEU OK for Roche's oral flu treatment Xofluza
MoSanofi to acquire Kymab for up to $1.45bn
MoEngland to launch rapid asymptomatic COVID-19 testing this week
08.01.BREAKING NEWS: Moderna's COVID-19 vaccine granted authorisation in UK
08.01.NHS Digital pilot will collect private hospital data
08.01.MHRA review recommends discussion around epilepsy medication and pregnancy
08.01.Tocilizumab and sarilumab cut risk of death in severe COVID-19 patients
08.01.NICE no for BMS' Opdivo for head and neck cancer
sist1